FDA approves Fentora for cancer pain

The FDA has approved Cephalon's Fentora for treating the pain of some cancer victims. The agency approved the drug for patients who can tolerate opioid therapy. Fentora includes fentanyl, a powerful pain killer that is used in other therapies as well. But Fentora is designed to be absorbed in the lining of the upper cheek, which researchers say can deliver pain relief much faster than other methods. The agency had already given conditional approval of Fentora, which will be used to treat sharp spikes in pain that can last anywhere from three to 60 minutes. Cephalon is also studying Fentora for other types of pain as well.

- here's a report on the approval from TheStreet.com

Suggested Articles

Bristol Myers Squibb may have bounced Jounce from its roster of inherited partners, but it’s hanging onto Anokion, a Swiss autoimmune-focused biotech.

The priority review action date sets Bristol Myers up to win approval for the bluebird-partnered anti-BCMA CAR-T therapy in late March.

The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up.